ABEONA THERAPEUTICS INC.ABEO

Market cap

$255.78M

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	2	396,000	424,000	12	40	69	138	19	130	14	39	15	15	24
Marketable securities, current	-	-	-	-	-	-	-	66	-	82	12	38	38	74
Total cash & short-term investments	2	396,000	424,000	12	40	69	138	86	130	96	51	52	53	98
Accounts receivable, net	-	-	-	-	-	-	-	-	-	-	3	-	-	-
Inventories	151,000	194,000	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets	3	2	575,000	12	41	69	141	89	132	98	55	53	56	101
Property, plant and equipment, net	51,000	7,000	6,000	4,000	350,000	721,000	1	9	13	11	12	6	4	4
Total non-current assets	472,000	49,000	38,000	5	39	42	38	86	91	53	24	11	8	8
Total assets	4	2	613,000	17	80	111	179	174	223	151	80	64	64	109
Accounts payable	2	2	863,000	2	875,000	4	2	6	4	5	4	2	2	3
Long-term debt, current	-	-	-	-	-	-	-	-	-	-	-	-	-	6
Total current liabilities	12	7	9	3	1	8	6	20	39	42	17	8	13	17
Long-term debt, non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	13
Total non-current liabilities	9	12	6	9	11	4	3	20	6	7	12	30	36	48
Total liabilities	21	19	15	12	12	12	9	40	45	49	28	37	49	65
Common stock and paid-in capital	238	251	252	301	378	403,000	469,000	479,000	836,000	961,000	698	722	764	857
Retained earnings	-255,441,000	-267,972,000	-266,421,000	-296,074,000	-310,600,000	-332,473,000	-359,792,000	-410,188,000	-486,470,000	-570,704,000	-655,640,000	-695	-749	-813
Stockholders' equity	-17,606,000	-17,076,000	-14,779,000	5	68	99	170	134	178	103	51	27	15	44
Total debt	-	-	-	-	-	-	-	-	-	-	-	-	-	19
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-79
D/E ratio (%)	-	-	-	-	-	-	-	-	-	-	-	-	-	43.1